Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03713762Phase 3Completed
Phase 3, randomised trial of fentanyl in cataract (2 arms), sponsored by Centro Médico Docente La Trinidad. Primary endpoint: Latency period (loss of corneal reflex) at 10 minutes. Started Oct 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03713762.